January 2016 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for January 2016. This roundup includes the latest...
Many Physicians Show Tendency to Undertreat With Statins
Target levels more likely to be achieved in departments that prescribe more statins
Comorbidity Affects Fitness-to-Drive Recs in Parkinson’s Disease
Physicians consider comorbidities, but on-road assessors may not
Proton Radiotherapy May Be New Option for Peds Brain Tumor
Acceptable toxicity, similar survival as conventional radiotherapy for childhood medulloblastoma
Mobile Texts May Up Adherence to Meds for Chronic Illness
Meta-analysis shows mobile phone text reminders double the odds of medication adherence
Opioids Don’t Ease Disability in Neuropathic Pain
Medications aren't useful in restoring motion, researchers say
Demand for Medical Office Space High and Increasing
Vacancy rate for medical office buildings 9.5 percent in third quarter of 2015; lowest since 2007
Tysabri Impacts Seroconversion in John Cunningham Virus
Over 14.8 months, natalizumab treatment linked to 15.9 percent increase of value in JCV+ patients
Carbamazepine Affects Warfarin Anticoagulation
Carbamazepine co-treatment linked to subtherapeutic anticoagulative effect of warfarin
AMA Highlights Top Four Issues to Promote in State Legislation
Issues include physician-led team-based care, improving patient health, reducing rx drug overdose
